Like a car gliding on cruise control, Ford (NYSE: F ) is keeping its quarterly dividend steady. For its Q2, the company will distribute $0.10 per share of both its common and class B stock on June 3 to shareholders of record as of May 3. That amount matches the previous disbursement, which was handed out in January. Prior to that, the carmaker paid $0.05 per share.
This marks the sixth consecutive quarterly payout for the company since it restarted its dividend payments in January 2012. It had suspended them following the April 2006 distribution of $0.10 per share.
The current dividend annualizes to $0.40 per share. That yields just under 3% at Ford's most recent closing stock price of $13.53.
Top 5 Managed Healthcare Companies To Invest In Right Now: M.D.C. Holdings Inc. (MDC)
M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company�s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.
Advisors' Opinion:- [By Dimitra DeFotis]
Colleague Dave Englander recommended taking profits in another medical device maker, Boston Scientific (BSX) in mid-August. At the time, he noted that stock was up 107% since his favorable recommendation had appeared, outpacing the Standard & Poor’s 500 Index by 80 points. He noted Boston Scientific faces competition from St. Jude and Medtronic (MDC), and he said that the market for stents and defibrillators has stabilized but is “not likely to grow meaningfully.” �(See “Time to Sell These Winners,” Aug. 14, subscription required.)
- [By Lisa Levin]
MDC Holdings (NYSE: MDC) shares fell 1.16% to touch a new 52-week low of $25.60. MDC Holdings' PEG ratio is 3.14.
PDF Solutions (NASDAQ: PDFS) shares reached a new 52-week low of $12.91. PDF Solutions updated the status of certain contracts and announced the effect of the change in status on previously deferred costs and expected revenues.
Best Up And Coming Companies To Own In Right Now: Illinois Tool Works Inc.(ITW)
Illinois Tool Works Inc. manufactures a range of industrial products and equipment worldwide. The company?s Transportation segment offers metal and plastic components, fasteners, and assemblies; fluids and polymers; fillers and putties; polyester coatings, and patch and repair products; and truck remanufacturing and related parts and service. Its Industrial Packaging segment offers steel and plastic strapping and related tools and equipment; plastic stretch film and related equipment; paper and plastic products that protect goods in transit; and metal jacketing products. The company?s Food Equipment segment provides warewashing, cooking, refrigeration, and food processing equipment; and kitchen exhaust, ventilation, and pollution control systems. Its Power Systems & Electronics segment provides arc welding equipment; metal arc welding consumables; metal solder materials for PC board fabrication; equipment and services for microelectronics assembly; electronic components an d component packaging; and airport ground support equipment. The company?s Construction Products segment offers anchors, fasteners, and related fastening tools for wood, metal, and concrete applications; metal plate truss components, and related equipment and software; and packaged hardware and other products for retail. Its Polymers & Fluids segment provides adhesives, chemical fluids, epoxy and resin-based coating products, hand wipes and cleaners, and pressure-sensitive adhesives and components. The company?s Decorative Surfaces segment offers laminate for furniture, office and retail space, and countertops; and laminate flooring and worktops. In addition, the company offers plastic reclosable packages and bags, and consumables; plastic and metal fasteners, and components; foil and film products; product coding and marking, paint spray, and static and contamination control equipment; and swabs and mats. The company was founded in 1912 and is based in Glenview, Illinois. Advisors' Opinion:
- [By Dividends4Life]
Related Articles
- Genuine Parts Company (GPC) Dividend Stock Analysis
- International Business Machines Corp. (IBM) Dividend Stock Analysis
- Monsanto Co. (MON) Dividend Stock Analysis
- Illinois Tool Works Inc. (ITW) Dividend Stock Analysis
- More Stock Analysis - [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Illinois Tool Works Inc.(ITW) raised its 2014 profit outlook and reported third-quarter earnings rose 17% as most of its business segments posted revenue growth and margins strengthened.
- [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number MSFT is trading at a premium to all four valuations above. The stock is trading at a 41.4% discount to its calculated fair value of $68.12. MSFT earned a Star in this section since it is trading at a fair value.Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% MSFT earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. MSFT earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 2003 and has increased its dividend payments for 12 consecutive years.Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA MSFT earned a Star in this section for its NPV MMA Diff. of the $14,663. This amount is in excess of the $2,300 target I look for in a stock that has increased dividends as long as MSFT has. If MSFT grows its dividend at 17.5% per year, it will take 2 years to
- [By Stoyan Bojinov]
Citigroup announced on Wednesday that it was maintaining a “Neutral” rating on the Glenview, IL-based industrial conglomerate, Illinois Tool Works (ITW), but went on to raise its price target for the company.
Deane Dray, an analyst with the firm, noted “Following its disclosure in February 2013 that it was reviewing strategic alternatives for its $2.4 bil Industrial Packaging business, ITW officially announced on Sept-24 that the sale process has begun. In an incremental positive, the company declared that all the dilution from the divestiture would be offset by buybacks and that additional balance sheet leverage will be used to fund the program.” Given the lagged benefit of the expected buyback, Citigroup raised its price target on the stock from $75 to $80 a share.
Illinois Tool Works shares traded lower on Wednesday, shedding 0.97% on the day. The stock is up 27% YTD.
Best Up And Coming Companies To Own In Right Now: Two Harbors Investment Corp (TWO)
Two Harbors Investment Corp. (Two Harbors), incorporated on May 21, 2009, operates as a real estate investment trust (REIT). The Company is focused on investing in, financing and managing residential mortgage-backed securities (RMBS), residential mortgage loans, residential real properties, and other financial assets. The Company focuses on security selection and implements a relative value investment approach across various sectors within the residential mortgage market. Its target assets include Agency RMBS, Non-Agency RMBS, residential mortgage loans, residential real properties and other financial assets comprising approximately 5% to 10% of the portfolio. The Company has designated certain of its subsidiaries as taxable REIT subsidiaries (TRSs). Capitol Acquisition Corp. (Capitol) is a wholly owned indirect subsidiary of Two Harbors. The Company is externally managed and advised by PRCM Advisers LLC, a wholly owned subsidiary of Pine River Capital Management L.P. (Pine River).
The Company invests primarily in mortgage pass-through certificates, collateralized mortgage obligations and other residential mortgage-backed securities representing interests in or obligations backed by pools of mortgage loans issued by Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Government National Mortgage Association (GNMA) (collectively GSEs). The Company also invests in residential mortgage-backed securities that are not issued by the GSEs (non-Agency RMBS) and United States Treasuries. At December 31, 2011, the Company had total assets of approximately $8.1 billion, of which $6.2 billion, or 77.1%, represented its RMBS portfolio. At December 31, 2011, $5.1 billion, or 80.9%, of its RMBS portfolio was comprised of Agency RMBS, $0.9 billion, or 14.9%, of its RMBS portfolio was comprised of senior non-Agency RMBS, and the remaining $0.2 billion, or 4.2%, was comprised of other non-Agency RMBS. The remaining $1.9 billion of assets consisted p! rimarily of United States Treasuries classified as trading instruments, cash, restricted cash, mortgage loans held-for-sale, receivables, derivative assets and prepaid assets.
Advisors' Opinion:- [By Lee Jackson]
Two Harbors Investment Corp. (NYSE: TWO) is a very wounded mortgage REIT that may offer big gains for investors. The company trades well below book value and has a nicely hedged portfolio. Merrill Lynch has a Buy rating on the stock and an $11 price target. The consensus target was not available. The stock closed yesterday at $9.65. Investors are paid an outstanding 11.3% dividend.
- [By Jon C. Ogg]
Two Harbors Investment Corp. (NYSE: TWO) has a Neutral rating with a $11.50 price target, but a $9.59 recent price in the report. Its book value was $10.48 at the end of the quarter and was projected to be $10.39 at the end of August.
Best Up And Coming Companies To Own In Right Now: Alexion Pharmaceuticals Inc.(ALXN)
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products for treating patients with severe and life-threatening disease states in the United States, Europe, Latin America, Japan, and the Asia Pacific. It focuses on developing products for the treatment of diseases in the areas of hematology, nephrology, neurology, ophthalmology, and cancer. The company develops and commercializes Soliris (eculizumab), a therapeutic product for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), a blood disorder. It also conducts various Phase II clinical trail programs on Soliris for its usage for the treatment of cold agglutinin disease; atypical hemolytic uremic syndrome; presensitized renal transplant; kidney transplant for catastrophic antiphospholipid syndrome; ABO incompatible renal transplant; dense deposit disease; myasthenia gravis; neuromyelitis optica; and dry a ge-related macular degeneration. In addition, the company conducts Phase IV clinical trails on Soliris for its usage for the treatment of PNH registry; and Phase I clinical trails on Samalizumab for the treatment of oncology diseases, such as chronic lymphocytic leukemia and multiple myeloma. Alexion Pharmaceuticals, Inc. serves specialty distributors and specialty pharmacies, which supply physician office clinics, hospital outpatient clinics, infusion clinics, or home health care providers; government agencies; and hospitals, hospital buying groups, pharmacies, other healthcare providers, and distributors. The company was founded in 1992 and is headquartered in Cheshire, Connecticut.
Advisors' Opinion:- [By Sean Williams]
Alexion Pharmaceuticals (NASDAQ: ALXN ) , for example, is currently worth more than $21 billion because of its focus on rare diseases. Its lone drug approved by the Food and Drug Administration, Soliris, is the most expensive drug in the world and is approved to treat a rare blood disorder known as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. This year alone, Soliris is expected to top $1.5 billion in sales.
- [By Heather Long]
Some of the stocks he likes now include: Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Actavis (ACT), and United Rentals (URI). All of these are up more than 20% this year with Illumina up over 50%.
No comments:
Post a Comment